Perilipin 1: a systematic review on its functions on lipid metabolism and atherosclerosis in mice and humans.
PLIN1
Acute coronary syndrome
Atherosclerosis
Lipid droplet
Lipodystrophy
Perilipin 1
Variant
Journal
Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427
Informations de publication
Date de publication:
14 Mar 2024
14 Mar 2024
Historique:
received:
29
06
2023
revised:
12
10
2023
accepted:
27
10
2023
medline:
18
3
2024
pubmed:
12
1
2024
entrez:
12
1
2024
Statut:
ppublish
Résumé
The function of perilipin 1 in human metabolism was recently highlighted by the description of PLIN1 variants associated with various pathologies. These include severe familial partial lipodystrophy and early onset acute coronary syndrome. Additionally, certain variants have been reported to have a protective effect on cardiovascular diseases. The role of this protein remains controversial in mice and variant interpretation in humans is still conflicting. This literature review has two primary objectives (i) to clarify the function of the PLIN1 gene in lipid metabolism and atherosclerosis by examining functional studies performed in cells (adipocytes) and mice and (ii) to understand the impact of PLIN1 variants identified in humans based on the variant's location within the protein and the type of variant (missense or frameshift). To achieve these objectives, we conducted an extensive analysis of the relevant literature on perilipin 1, its function in cellular models and mice, and the consequences of its mutations in humans. We also utilized bioinformatics tools and consulted the Human Genetics Cardiovascular Disease Knowledge Portal to enhance the pathogenicity assessment of PLIN1 missense variants.
Identifiants
pubmed: 38214891
pii: 7517630
doi: 10.1093/cvr/cvae005
doi:
Substances chimiques
Perilipin-1
0
Perilipin-2
0
Phosphoproteins
0
Plin1 protein, mouse
0
PLIN1 protein, human
0
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
237-248Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Déclaration de conflit d'intérêts
Conflict of interest: none declared.